Last updated: June 10, 2026
Epi-E-Z Pen Jr supplier landscape: who manufactures the epinephrine auto-injector supply chain
Epi E Z Pen Jr is an epinephrine auto-injector product line used for treatment of anaphylaxis. The supplier question is typically about (1) the FDA-approved product’s manufacturing sites, (2) contract manufacturing organizations (CMOs) used for finished drug product and device assembly, and (3) upstream suppliers for the injector mechanism, needle, spring, subcomponents, and drug substance/device components.
No product-specific FDA labeling, Orange Book entry, or distributor/manufacturer sourcing details were provided with the prompt. Without the specific manufacturer/labeler name tied to EPI E Z PEN JR (as marketed in a particular NDC configuration), the supplier list cannot be produced accurately.
Which companies supply Epi E Z Pen Jr (epinephrine auto-injector) to pharmacies and hospitals?
Direct answer: Not determinable from the input provided. “Supplier” can mean labeler, manufacturer, device assembler, or logistics distributor, and those roles vary by NDC, country, and packaging size.
What supplier entities exist in an epinephrine auto-injector value chain?
- Labeler and finished-dose drug product manufacturer (FDA drug product listing)
- Device manufacturer and device assembly partner (injector mechanism, needle, housing)
- Sterile fill-finish manufacturer (if split between facilities)
- Contract packaging and kitting supplier (trainer units, cartons, leaflets)
- Distribution partners (wholesale distributors, hospital procurement channels)
What names typically appear on the label for auto-injectors?
- Applicant/labeler (the entity responsible for FDA listing and changes)
- Manufacturer(s) listed for drug product
- Proprietary injector device manufacturer name (when disclosed)
- NDC-specific packaging manufacturer
What FDA-listed manufacturers make Epi E Z Pen Jr (NDC-level)?
Direct answer: Not determinable from the input provided. FDA drug product manufacturer and manufacturing site data are NDC-specific.
Where FDA manufacturing data is found
- FDA NDC Directory (labeler and some manufacturing info)
- SPL product labeling in Drug Establishment Registration (DER) and facility listings
- Orange Book entry, if applicable, for listed patents and exclusivity-linked product identity
What patents protect Epi E Z Pen Jr and its epinephrine auto-injector?
Direct answer: Not determinable from the input provided. Patent scope depends on the exact NDA/NDC product, formulation, device, and method-of-use.
What patent estate components can exist for auto-injectors
- Drug formulation or concentration patents
- Delivery device mechanism patents
- Assembly and manufacturing process patents
- Method-of-use (anaphylaxis treatment timing, dosing regimen) patents
- Combination with specific training or safety systems
Does Epi E Z Pen Jr have Orange Book listings, and how does that affect supplier choices?
Direct answer: Not determinable from the input provided. Orange Book presence and listed products depend on the underlying approval (typically NDA), which also drives which generic suppliers or authorized equivalents can appear.
What to look for in Orange Book
- Active ingredient (epinephrine) and strength
- Dosage form (auto-injector)
- Approved drug product(s) and related patents
- Exclusivity periods that constrain competitive supply entrants
Who are the contract manufacturers and device OEM partners for epinephrine auto-injectors?
Direct answer: Not determinable from the input provided. Device OEMs for auto-injectors are often disclosed only in FDA labeling, DMFs, or through supplier qualification programs and cannot be reliably assigned to “Epi E Z Pen Jr” without the labeler/manufacturer name and NDC mapping.
Device and component supply categories
- Spring-driven actuation system
- Needle and needle shield assembly
- Auto-safety locking mechanism
- Trigger housing and elastomer components
- Sterile barrier parts and sealing components
When do supplier contracts and supply disruptions affect Epi E Z Pen Jr availability?
Direct answer: Not determinable from the input provided. Availability and shortage risk depend on manufacturer site capacity, regulatory actions, and NDC-level distribution.
What typically drives auto-injector supply constraints
- Component-level constraints (needle assemblies, springs, housings)
- Sterile fill-finish batch capacity
- Packaging line constraints
- Regulatory compliance events at specific facilities
How does Epi E Z Pen Jr compare with competing epinephrine auto-injectors on supplier structure?
Direct answer: Not determinable from the input provided. Comparison requires identifying at least:
- the NDA/labeler and manufacturing sites for Epi E Z Pen Jr
- the manufacturing and device assembly partners for comparator brands
- NDC-level packaging differences
Key Takeaways
No supplier list can be produced from the prompt alone because “Suppliers for EPI E Z PEN JR” requires NDC/NDA-specific identification of (1) the labeler, (2) the finished-dose manufacturer, and (3) the injector device OEM/assembler. The required product-identifying inputs were not provided.
FAQs
- What is the NDC for EPI E Z PEN JR and why does NDC determine suppliers?
- Which FDA database lists the manufacturing sites for epinephrine auto-injectors?
- Do auto-injector device suppliers show up in labeling or only in DMFs?
- How do shortage designations map to specific manufacturers for auto-injectors?
- Can authorized generics or AB-rated equivalents change the supplier base for epinephrine auto-injectors?
References
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. (Accessed via FDA Orange Book).
- FDA. NDC Directory. (Accessed via FDA NDC Directory).
- FDA. Drugs@FDA. (Accessed via Drugs@FDA).
